D-0151-2025 Class II Ongoing

Recalled by Apothecus Pharmaceutical Corp. — Hicksville, NY

FDA drug recall D-0151-2025 was initiated by Apothecus Pharmaceutical Corp. on Nov 22, 2024 and is designated Class II. Reason for recall: CGMP deviations: out of specifications for assay The recall status is ongoing. Affected quantity: 33,659 retail boxes in US.

Recall details

Product Type
Drugs
Report Date
Dec 25, 2024
Initiation Date
Nov 22, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
33,659 retail boxes in US

Product description

VCF, Vaginal Contraceptive Gel, Birth Control, 10 Pre-filled Applicators, Net Wt. 0.09 oz (2.55g) Each, Distributed By: Apothecus Pharmaceutical Corp., Ronkonkoma, NY 11779, NDC 52925-512-10

Reason for recall

CGMP deviations: out of specifications for assay

Distribution pattern

Nationwide in the USA and 2 Distributors in Hong Kong

Code information

Lot: 3A001/3A001A, Exp: 07/25

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0151-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0151-2025. Report a data issue: hello@regdatalab.com.